The 24 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 168.50, with a high estimate of 205.00 and a low estimate of 135.00. The median estimate represents a +17.50% increase from the last price of 143.40.
The current consensus among 28 polled investment analysts is to Hold stock in Abbvie Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $2.80
Reporting Date Jan 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.